• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TELEFLEX MEDICAL ARROWG+ARD BLUE CENTRAL VENOUS CATHETER (CVC); CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TELEFLEX MEDICAL ARROWG+ARD BLUE CENTRAL VENOUS CATHETER (CVC); CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Patient Problems Hypersensitivity/Allergic reaction (1907); Low Blood Pressure/ Hypotension (1914); Tachycardia (2095)
Event Date 01/03/2024
Event Type  Injury  
Event Description
Intraoperatively, after placement of the central line catheter, the patient did have an allergic reaction and developed tachycardia with hypotension.Patient did receive epinephrine boluses and a drip.Did become stable and continued on with procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROWG+ARD BLUE CENTRAL VENOUS CATHETER (CVC)
Type of Device
CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
TELEFLEX MEDICAL
MDR Report Key18589908
MDR Text Key333961205
Report NumberMW5150790
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 01/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/25/2024
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age75 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-